Cold and flu ingredient to be removed over allergy link A plant ingredient found in dozens of cold and flu supplements on the market will be taken off the shelves, Australia's medicine regulator has announced. AAP · Sep 21
Peptide user tore oesophagus after using counterfeit product, Australian regulator warns TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutide The Guardian - AU · Sep 14
Australian Influencer's Extreme 'Barbie Waist' Lets Boyfriend Wrap Hands Around It But Doctors Warn of Organ Damage Australian influencer Matilda Baxter has faced renewed concern after showcasing her dramatically narrowed waist, prompting debate over cosmetic procedures, body image and the risks of extreme beauty trends. International Business Times UK · Sep 11
Ultra Violette Details New SPF Testing Process Almost A Year After Lean Screen Recall Almost a year after Ultra Violette’s Lean Screen recall put the brand at the centre of Australia’s sunscreen testing controversy, the company has detailed a new SPF testing and review process for its products. The sunscreen brand announced the updated approach to customers last Friday, days before Velvet Screen… Pedestrian.tv · Aug 21
Defibs still safe despite reported shutdowns, TGA says Health authorities have defended the continued use of defibrillators in ambulances after a regulator stepped in to put a halt on sales of the devices. AAP · Aug 12
Rise in adulterated sexual enhancement supplements could mean users are getting stiffed Often sold as ‘herbal’ solutions for sexual prowess, research has found many supplements are cut with prescription medications that could harm the people who take them The Guardian - AU · Aug 4
Clinicians are using AI scribes, but what happens to your medical data? Visits to a new doctor, physio or specialist often begin with: “Do you mind if I use AI?” The Conversation · Aug 3
‘Prioritising profit’: Australians regularly prescribed medicinal cannabis with very high THC levels Exclusive: Of more than 1,000 medicinal cannabis products available, only two have been evaluated by the drug regulator The Guardian - AU · Jul 29
Australian regulator warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic TGA says product information for some diabetes and weight loss drugs updated with warning of NAION disorder The Guardian - AU · Jul 24
How wellness clinics bend the rules to supply unapproved peptides and anti-ageing injections Across Australia, “longevity” and “wellness” clinics, most of them online, sell injections that promise to slow ageing, build muscle, heal injuries and help you sleep. The Conversation · Jul 21
At-home STI test pulled from Australian shelves after failing to detect infections Exclusive: TGA finds Touch Biotechnology test for chlamydia and gonorrhoea ‘is not reliable’ and has affected an unspecified number of people The Guardian - AU · Jul 20
There’s one reason why so many cold and flu tablets don’t actually work You’ve got the sniffles and your nose is running like a tap. The tissues feel like sandpaper. The Conversation · Jul 13
Australia banned vape ads more than two years ago – so why are they still all over social media? Posts promoting illegal products appear across TikTok, Instagram and YouTube as expert says platforms ‘aren’t doing the job they promised they would do’ The Guardian - AU · Jul 13
Doctors’ soaring use of AI scribes prompts Australian government warning over privacy Exclusive: With the technology fast becoming popular in GP surgeries, regulators are monitoring its implementation and potential pitfalls The Guardian - AU · Jul 4
The Guardian - AU · Jun 16 One Nation’s health policies based on misconceptions and may cost the taxpayer, experts warn Former Howard-era adviser says Pauline Hanson’s party is channelling Donald Trump’s health agenda
Newcastle Herald · Jun 14 Inside the peptides trend: 'A pretty big gamble to take with your health' Peptides have been linked to the 'looksmaxxing' trend.
The Guardian - AU · Jun 10 Burke brushes off One Nation threat to his seat – as it happened All the day’s news as it unfolded
AAP · Jun 3 Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that the Therapeutic Goods Administration (TGA) of Australia granted approval with conditions of…
The Conversation · May 8 Higher-strength medicinal cannabis may be linked to a disturbing pattern of side effects, our study shows In recent years, we’ve seen a sizeable shift in medicinal cannabis prescribing, to products containing higher levels of THC (tetrahydrocannabinol) – the component that can cause drowsiness or a high.
The Conversation · May 6 Can’t get your HRT patches? What to do and what to avoid Since 2020, Australia has had an ongoing shortage of oestrogen patches, which are usually prescribed to help ease menopause symptoms.
The Independent UK · Apr 16 Are people still travelling to Turkey? The March tourist numbers are in IN FULL
The Independent UK · Apr 16 Turkish tourist numbers rise despite global travel chaos, tourist board says Visits and bookings were both up in the month of March to Turkey
The Conversation · Apr 10 What is andrographis, the cold and flu ingredient the TGA says can be fatal? A herb commonly sold in cold and flu supplements may no longer be classified as “low-risk”, after Australia’s therapeutic goods regulator found it can cause severe allergic reactions and even death.
The Conversation · Apr 2 As the Iran war disrupts supplies, will it affect access to medicines? As the conflict in the Middle East disrupts fuel, shipping and food supplies, many are starting to ask if they will be still be able to get their medicines if the war drags on.
The Conversation · Mar 31 Will medicinal cannabis help my mental health? Here are the evidence and the risks Anxiety, depression and post-traumatic stress disorder (PTSD) are among the most common mental health conditions for which Australians are prescribed medicinal cannabis.